# A Pilot Study of Aerosol Interferon-gamma for Treatment of Idiopathic Pulmonary Fibrosis

> **NCT00563212** · PHASE1 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 12 (actual)

## Conditions studied

- Pulmonary Fibrosis

## Interventions

- **DRUG:** aerosol interferon-gamma

## Key facts

- **NCT ID:** NCT00563212
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2010-06-01
- **Final completion:** 2018-12-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-04-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00563212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00563212, "A Pilot Study of Aerosol Interferon-gamma for Treatment of Idiopathic Pulmonary Fibrosis". Retrieved via MORVS 2026-11-02 from https://api.morvs.ai/clinical/NCT00563212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*